Hubert Fleury

864 total citations
13 papers, 390 citations indexed

About

Hubert Fleury is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Hubert Fleury has authored 13 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 3 papers in Biomedical Engineering. Recurrent topics in Hubert Fleury's work include PARP inhibition in cancer therapy (6 papers), DNA Repair Mechanisms (5 papers) and CRISPR and Genetic Engineering (3 papers). Hubert Fleury is often cited by papers focused on PARP inhibition in cancer therapy (6 papers), DNA Repair Mechanisms (5 papers) and CRISPR and Genetic Engineering (3 papers). Hubert Fleury collaborates with scholars based in Canada, United Kingdom and New Zealand. Hubert Fleury's co-authors include Anne‐Marie Mes‐Masson, Diane Provencher, Eurı́dice Carmona, Laudine Communal, Sophie Gilbert, Nicolas Malaquin, Marc‐Alexandre Olivier, Aurélie Martinez, Françis Rodier and Jean‐Yves Masson and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Molecular Cell.

In The Last Decade

Hubert Fleury

13 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hubert Fleury Canada 11 224 179 99 69 48 13 390
Sophie Gilbert Canada 6 180 0.8× 85 0.5× 128 1.3× 63 0.9× 35 0.7× 9 308
Rachel Roberson United States 7 332 1.5× 144 0.8× 246 2.5× 71 1.0× 53 1.1× 8 510
Jane Antony United States 10 207 0.9× 185 1.0× 23 0.2× 165 2.4× 79 1.6× 16 448
Marco Proietto United States 9 246 1.1× 110 0.6× 24 0.2× 59 0.9× 52 1.1× 12 394
Alicja Trębińska Poland 11 244 1.1× 87 0.5× 109 1.1× 114 1.7× 94 2.0× 18 487
Orlev Levy‐Nissenbaum Israel 8 202 0.9× 105 0.6× 57 0.6× 73 1.1× 57 1.2× 10 355
Sinéad Lindsay Ireland 7 321 1.4× 59 0.3× 23 0.2× 54 0.8× 179 3.7× 7 400
Pauline J. van der Watt South Africa 14 546 2.4× 144 0.8× 24 0.2× 23 0.3× 61 1.3× 23 682
Charlotte Beaver United Kingdom 6 184 0.8× 60 0.3× 43 0.4× 32 0.5× 34 0.7× 7 281
Chih‐Yung Yang Taiwan 11 215 1.0× 80 0.4× 18 0.2× 56 0.8× 131 2.7× 24 420

Countries citing papers authored by Hubert Fleury

Since Specialization
Citations

This map shows the geographic impact of Hubert Fleury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hubert Fleury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hubert Fleury more than expected).

Fields of papers citing papers by Hubert Fleury

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hubert Fleury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hubert Fleury. The network helps show where Hubert Fleury may publish in the future.

Co-authorship network of co-authors of Hubert Fleury

This figure shows the co-authorship network connecting the top 25 collaborators of Hubert Fleury. A scholar is included among the top collaborators of Hubert Fleury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hubert Fleury. Hubert Fleury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Fleury, Hubert, Roopesh Anand, Kerri A. Ball, et al.. (2023). The APE2 nuclease is essential for DNA double-strand break repair by microhomology-mediated end joining. Molecular Cell. 83(9). 1429–1445.e8. 24 indexed citations
2.
Allard, David, Isabelle Cousineau, H. Eric, et al.. (2023). The CD73 immune checkpoint promotes tumor cell metabolic fitness. eLife. 12. 11 indexed citations
3.
Péant, Benjamin, et al.. (2022). Pre-activation of autophagy impacts response to olaparib in prostate cancer cells. Communications Biology. 5(1). 251–251. 14 indexed citations
4.
Boudhraa, Zied, Kossay Zaoui, Hubert Fleury, et al.. (2021). NR1D1 regulation by Ran GTPase via miR4472 identifies an essential vulnerability linked to aneuploidy in ovarian cancer. Oncogene. 41(3). 309–320. 9 indexed citations
5.
Simeone, Kayla, et al.. (2021). Carboplatin response in preclinical models for ovarian cancer: comparison of 2D monolayers, spheroids, ex vivo tumors and in vivo models. Scientific Reports. 11(1). 18183–18183. 29 indexed citations
6.
Patra, Bishnubrata, Hubert Fleury, Eurı́dice Carmona, et al.. (2020). Carboplatin sensitivity in epithelial ovarian cancer cell lines: The impact of model systems. PLoS ONE. 15(12). e0244549–e0244549. 20 indexed citations
7.
Fleury, Hubert, Nicolas Malaquin, Sophie Gilbert, et al.. (2019). Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence. Nature Communications. 10(1). 2556–2556. 162 indexed citations
8.
Péant, Benjamin, et al.. (2019). Long-term fluorescence hyperspectral imaging of on-chip treated co-culture tumour spheroids to follow clonal evolution. Integrative Biology. 11(4). 130–141. 5 indexed citations
9.
Couturier, Anthony M., Hubert Fleury, Anne‐Marie Patenaude, et al.. (2016). Roles for APRIN (PDS5B) in homologous recombination and in ovarian cancer prediction. Nucleic Acids Research. 44(22). 10879–10897. 39 indexed citations
10.
Jangal, Maïka, et al.. (2016). Proximal and distal regulation of the HYAL1 gene cluster by the estrogen receptor α in breast cancer cells. Oncotarget. 7(47). 77276–77290. 12 indexed citations
11.
Fleury, Hubert, Eurı́dice Carmona, Vincent Morin, et al.. (2016). Cumulative defects in DNA repair pathways drive the PARP inhibitor response in high-grade serous epithelial ovarian cancer cell lines. Oncotarget. 8(25). 40152–40168. 23 indexed citations
12.
Fleury, Hubert, Laudine Communal, Eurı́dice Carmona, et al.. (2015). Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary disease. Genes & Cancer. 6(9-10). 378–398. 26 indexed citations
13.
Marques, Maud, Marie‐Claude Beauchamp, Hubert Fleury, et al.. (2015). Chemotherapy reduces PARP1 in cancers of the ovary: implications for future clinical trials involving PARP inhibitors. BMC Medicine. 13(1). 217–217. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sophie Gilbert Breakdown of academic impact, for papers by Rachel Roberson Breakdown of academic impact, for papers by Jane Antony Breakdown of academic impact, for papers by Marco Proietto Breakdown of academic impact, for papers by Alicja Trębińska Breakdown of academic impact, for papers by Orlev Levy‐Nissenbaum Breakdown of academic impact, for papers by Sinéad Lindsay Breakdown of academic impact, for papers by Pauline J. van der Watt Breakdown of academic impact, for papers by Charlotte Beaver Breakdown of academic impact, for papers by Chih‐Yung Yang
Rankless by CCL
2026